UT Southwestern Medical Center recently landed more than $22 million in grants from the state of Texas to research leukemia, liver cancer, and immunotherapy.
The Cancer Prevention and Research Institute of Texas announced the grants on Monday. The majority—$18 million—will go toward recruiting additional faculty. Researchers received $2 million to study a new antibody therapy for treating leukemia; $1.35 million to research liver cirrhosis and hepatocellular carcinoma; and $1.1 million to study a receptor for anti-cancer immunotherapy.
“We are grateful to CPRIT and the people of Texas for their continued support of investigators at UT Southwestern, as reflected by these awards. These funds will enable our faculty and their teams to drive important advances that will lead to better care for cancer patients,” said Dr. Daniel K. Podolsky, the university’s president, in a prepared statement.
Continue reading at D Healthcare Daily.